Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esper Kallas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|June 10, 2014
Hyperreactive Malarious Splenomegaly and AIDS: a case reportZuleica Naomi Tano, Chafic Esper Kallas Filho, Regina Mitsuka Breganó, et al.
Journal of Clinical Microbiology|November 8, 2014
Streamlining HIV testing for HIV preexposure prophylaxisJuan V Guanira, Teri Leigler, Esper Kallas, et al.
Andrology|September 2, 2020
SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemicJorge Hallak, Thiago A Teixeira, Felipe S Bernardes, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 14, 2010
Acute HIV infection with rapid progression to AIDSMarcio de Oliveira Silva, Milena Bastos, Eduardo Martins Netto, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Frontiers in Immunology|March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
Scientific Reports|January 5, 2023
Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivorsSaulo Gil, Bruno Gualano, Adriana Ladeira de Araújo, et al.
Vaccine|July 31, 2025
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trialJosé Moreira, Elizabeth G Patiño, Patricia Emilia Braga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2018
Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8<sup>+</sup> T CellsAlba Grifoni, Priscilla Costa-Ramos, John Pham, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 2, 2025
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionMary A Rodgers, Francisco Averhoff, Michael G Berg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|June 10, 2014
Hyperreactive Malarious Splenomegaly and AIDS: a case reportZuleica Naomi Tano, Chafic Esper Kallas Filho, Regina Mitsuka Breganó, et al.
Journal of Clinical Microbiology|November 8, 2014
Streamlining HIV testing for HIV preexposure prophylaxisJuan V Guanira, Teri Leigler, Esper Kallas, et al.
Andrology|September 2, 2020
SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemicJorge Hallak, Thiago A Teixeira, Felipe S Bernardes, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|September 14, 2010
Acute HIV infection with rapid progression to AIDSMarcio de Oliveira Silva, Milena Bastos, Eduardo Martins Netto, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Frontiers in Immunology|March 30, 2026
AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702Ferdinando Menezes, Shiyu Chen, Nicole Grunenberg, et al.
Scientific Reports|January 5, 2023
Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivorsSaulo Gil, Bruno Gualano, Adriana Ladeira de Araújo, et al.
Vaccine|July 31, 2025
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac) in Brazilian healthcare professionals: The PROFISCOV trialJosé Moreira, Elizabeth G Patiño, Patricia Emilia Braga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2018
Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8<sup>+</sup> T CellsAlba Grifoni, Priscilla Costa-Ramos, John Pham, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 2, 2025
Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionMary A Rodgers, Francisco Averhoff, Michael G Berg, et al.
Pageof 1